Xuejian Wu

Senior Partner of Rayto Law Firm & Head of the Search & Consulting Department

Lawyer & Patent Agent

Email: xj.wu@raytoip.com

Tel: +86 135 8514 1356

Nanjing,SuZhou
WeChat QR code
Rayto Positions

Senior Partner of Rayto Law Firm & Head of the Search & Consulting Department of Rayto

Practicing qualification

Lawyer & Patent Agent

Area of expertise

Patent Dispute Resolution

Patent Application (Mechanical)

Patent Application (Biomedicine)

Personal Profile

Senior Partner of Rayto, Head of the Search & Consulting Department, Lawyer & Patent Agent.

Overseas Intellectual Property Dispute Response Guidance Expert of Jiangsu Province, Foreign-Related Lawyer Talent of Jiangsu Province, Intellectual Property Backbone Talent of Jiangsu Province, Review Expert of the National Postdoctoral Innovation and Entrepreneurship Competition, Part-time Intellectual Property Dispute Mediator of Jiangsu Province, and "Outstanding Training Lecturer" of the Library of the University of Science and Technology of China; specializes in patent portfolio layout, patent litigation, patent search and consultation, technology licensing and transaction negotiation, trade secret protection and intellectual property due diligence; has provided intellectual property strategic consulting and planning for multiple technology enterprises during their IPO process, assisted multiple clients in completing intellectual property due diligence and reverse due diligence during investment and financing, led the completion of multiple cross-border technology licensing/intellectual property transaction negotiations, and handled over a hundred cases involving patent litigation/patent invalidation/trademark litigation, etc., and hosted multiple cases with national influence such as the confidentiality examination patent invalidation case (Top 10 Patent Reexamination and Invalidation Cases of 2022 – Case 4).

Tel: 13585141356

Email: xuejian129@163.com, xj.wu@raytoip.com

Practice Areas

New materials, new energy, fine chemicals, small-molecule drugs and intelligent manufacturing, and services such as intellectual property litigation, due diligence, technology transfer and intellectual property strategic consulting for IPO.

Representative Cases

【Intellectual Property Litigation and Invalidation Cases】

China's first national case of invalidation under the confidentiality examination clause (awarded Top 10 Patent Reexamination and Invalidation Cases of 2022 – Case 4);

LINAK v. Kaidi Electric invention patent litigation, with an amount in dispute of over 20 million yuan, represented the defendant and won, (2020) Supreme People's Court IP Civil Final No. 668;

"Internet-famous spin mop" patent invalidation and administrative litigation (the first 12 invalidation attempts were upheld), represented the defendant and won, (2021) Supreme People's Court IP Administrative Final No. 433;

Jinsheng spherical lamp patent litigation, patent invalidation and administrative litigation, represented the defendant and won, (2023) Supreme People's Court IP Administrative Final No. 885;

Intelligent hanging production line patent administrative litigation (judgment changed the patent invalidation decision), represented the plaintiff and won, (2023) Supreme People's Court IP Administrative Final No. 1228;

Compressor trademark infringement litigation case, represented the defendant and won, (2023) Su 05 Civil First Instance No. 371;

"Street lamp" patent invalidation case (design modification beyond scope), represented the petitioner and obtained full invalidation, Case No.: 6W115054;

"Automatic door lock" patent invalidation case (conflicting application), represented the petitioner and obtained full invalidation, Case No.: 5W126137;

【Technology Licensing and Non-Litigation Consulting】

Intellectual property due diligence for the over 100-million-yuan financing of U.S. Arthrosi Therapeutics (AR882 hyperuricemia drug has entered clinical trials);

Led the completion of patent due diligence for multiple series of new chemical entity drugs such as XYF and ZM326 (among them, the XYF ulcerative colitis drug has entered clinical trials);

Technology transfer and patent licensing negotiation between Nanjing University and U.S. Enspired Solution (awarded the first batch of Top 10 National Typical Cases Promoting Patent Transformation and Application by the All-China Patent Agents Association – Case 7);

Resolution of a patent ownership dispute between a "Double First-Class" university and the University of Texas at Austin (UT-Austin);

Patent licensing negotiation between a research institute of the Chinese Academy of Sciences and an innovative pharmaceutical enterprise (involving a licensing amount of over 100 million yuan);

Technology transfer and patent licensing negotiation between a "Double First-Class" university and U.S. A2 Intellectual Properties, LLC;

Patent infringement risk analysis for coupling products (Jakarta–Bandung High-Speed Railway in Indonesia);

【Government Consulting Projects】

Nanjing Municipal Service Project for Building a Provincial Intellectual Property Protection Demonstration City (NJXYS-2022130G-2);

Suzhou Key Field Intellectual Property Protection Project (SZRF2023-C-003);

Anhui Province Large Enterprise Overseas Intellectual Property Risk Early-Warning Project (GN2022-18-2385);

Anhui Province Overseas Intellectual Property Risk Early-Warning Project (AHZSCQ-F20210901);

【Awards】

First Prize in the First "Jinling Cup" Legal Service Innovation Product Competition (winning work: "Comprehensive Intellectual Property Legal Services for Sci-Tech Innovation Board IPO Preparatory Enterprises"), Nanjing Lawyers Association;

Second Prize in the Second "Jinling Cup" Legal Service Innovation Product Competition (winning work: "Intellectual Property Due Diligence Legal Services During the Investment and Financing Process of Technology Enterprises"), Nanjing Lawyers Association;

Outstanding Foreign-Related Legal Service Case of the Third "Jinling Lawyers Forum," case name: "Intellectual Property Due Diligence Case During the Investment Process of a Multinational Technology Enterprise," Nanjing Lawyers Association;

First Prize for Outstanding Intellectual Property Case of 2021, case name: "Linear Actuator Invention Patent Infringement Dispute Case," Nanjing Lawyers Association;

【Standards / Papers】

Wu Xuejian, Jiang Haijun*, Hu Fengfeng, et al. Discussion on the Divisional Application System and Application Strategies [J]. Patent Agency, 2021 (1): 46-50.

Wu Xuejian, Wang Yujiao, Chen Bin, et al. Exploring the Patent Portfolio Layout Strategy for New Chemical Entities in Combination with the R&D Process [J]. Patent Agency, 2021 (2): 48-58.

Wu Xuejian. Reasonably Defining the Scope of Protection of Well-Known Trademarks [N/OL]. China Intellectual Property News, 2024-02-21.

Jiang Haijun, Wu Xuejian, Chen Bin. Overview of the Thai Patent System and Application Process [J]. Patent Agency, 2019 (3): 63-66.

Wu Xuejian, Jiang Haijun*, Zhang Lanlan, et al. Application of the Confidentiality Examination Clause in the Patent Invalidation Process Based on Intelligence Search [J]. Patent Agency, 2024 (1): 89-96.

Wu Xuejian, Wang Mingyue, Zheng Jianping, et al. Empirical Research on the Application of the Confidentiality Examination Clause in Patent Invalidation Cases — Based on 21 Confidentiality Examination Invalidation Cases [J]. Patent Agency, 2025 (1): 85-93.

Participated in drafting the local standard "Specification for Pre-Examination of Patent Reexamination Requests (DB 3210/T 1154-2023)"

Participated in drafting the local standard "Specification for Enterprise Intellectual Property Analysis Services (DB3201/T1221-2024)"

Participated in drafting the local standard "Specification for Pre-Examination of Patent Invalidation Declaration Requests (DB3201/T 1222-2024)"

Related links